Sumitomo Mitsui Trust Group’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
LFCM
CS
B
Sumitomo Mitsui Trust Group's CLLS Position: Q1 2022 in Review
Sumitomo Mitsui Trust Group sold out of Cellectis (CLLS) in Q1 2022, closing a stake of 627,910 shares — an estimated $5.1M sold.
Sumitomo Mitsui Trust Group first reported a position in CLLS in Q1 2019 and held it in 12 quarters. The position peaked at $21.9M in Q4 2019. 51 funds tracked by Wall St. Rank hold CLLS as of Q1 2022.
- Sumitomo Mitsui Trust Group reported no remaining Cellectis position as of Q1 2022 after selling out during the quarter.
- Sumitomo Mitsui Trust Group sold 627,910 Cellectis shares in Q1 2022, an estimated $5.1M.
- Sumitomo Mitsui Trust Group first reported a position in Cellectis in Q1 2019 and held it in 12 quarters.
- Sumitomo Mitsui Trust Group's Cellectis position peaked at $21.9M in Q4 2019.
- 51 funds tracked by Wall St. Rank held Cellectis as of Q1 2022.
Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2022, filed 27 Apr 2022.